An underground market for unlicensed slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Traction Online
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before directing buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of uncertain source.
Several experts said the popularity for retatrutide could be connected to the rising price of approved slimming treatments such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, risking penalties, legal action or imprisonment.
Platform Reaction and Content Elimination
Based on the social media company, the platform has taken down violative material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform secure and investing in strengthening compliance measures.
Digital Marketplace Activities
Investigations also discovered communities with up to nine thousand members selling retatrutide using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, populated with images of slimming results, positive reviews and detailed guides for mixing or administering at home.
Within moments of entering one community, a vendor posted WhatsApp details, where most transactions occur. The seller provided an instruction manual and promised delivery within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one asked about body mass, medical conditions or past usage.
Product Information and Costs
Within these groups, posts display black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Oversight and Safety Measures
A representative for the messaging service stated it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current price rises for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her staff has previously encountered individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially significant health risks”.
